Intensity‐modulated or conformal radiotherapy improves the quality of life of patients with nasopharyngeal carcinoma

It was reported previously that the dosimetric superiority of conformal radiotherapy (RT), either 3‐dimensional conformal RT (3D‐CRT) or intensity‐modulated RT (IMRT), over conventional 2D‐RT translated into clinical benefits for patients with nasopharyngeal carcinoma (NPC). In this study, the authors compared quality‐of‐life (QOL) outcomes of NPC survivors who received treatment with 1 of 4 different RT techniques at a single institute during different periods.

[1]  P. Fayers,et al.  Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  P Xia,et al.  Comparison of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma. , 2000, International journal of radiation oncology, biology, physics.

[3]  G. Lockwood,et al.  Postradiotherapy quality of life for head-and-neck cancer patients is independent of xerostomia. , 2005, International journal of radiation oncology, biology, physics.

[4]  J. Sham,et al.  Intensity‐modulated radiotherapy for early‐stage nasopharyngeal carcinoma , 2004, Cancer.

[5]  J. Sham,et al.  Preservation of quality of life after intensity‐modulated radiotherapy for early‐stage nasopharyngeal carcinoma: Results of a prospective longitudinal study , 2006, Head & neck.

[6]  P. Xia,et al.  Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. , 2001, International journal of radiation oncology, biology, physics.

[7]  W. Kuo,et al.  Health-related quality of life for nasopharyngeal carcinoma patients with cancer-free survival after treatment. , 2002, International journal of radiation oncology, biology, physics.

[8]  Heikki Joensuu,et al.  Intensity modulated radiotherapy for head and neck cancer: evidence for preserved salivary gland function. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[9]  K. Rosenzweig,et al.  Failure of a 3D conformal boost to improve radiotherapy for nasopharyngeal carcinoma. , 2001, International journal of radiation oncology, biology, physics.

[10]  U. Abacıoğlu,et al.  Assessment of quality of life of nasopharyngeal carcinoma patients with EORTC QLQ-C30 and H&N-35 modules. , 2005, International journal of radiation oncology, biology, physics.

[11]  L. Dawson,et al.  Quality of life after parotid-sparing IMRT for head-and-neck cancer: a prospective longitudinal study. , 2003, International journal of radiation oncology, biology, physics.

[12]  D. Osoba,et al.  Interpreting the significance of changes in health-related quality-of-life scores. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  C. Tsien,et al.  Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report. , 2005, International journal of radiation oncology, biology, physics.

[14]  P. Xia,et al.  Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience. , 2000, International journal of radiation oncology, biology, physics.

[15]  D. Osoba,et al.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.

[16]  M. King.  The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30 , 1996, Quality of Life Research.

[17]  M. Zelefsky,et al.  Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience. , 2006, International journal of radiation oncology, biology, physics.

[18]  F. Fang,et al.  Implications of quantitative tumor and nodal regression rates for nasopharyngeal carcinomas after 45 Gy of radiotherapy. , 2001, International journal of radiation oncology, biology, physics.

[19]  D. Osoba,et al.  Quality of life and oral function following radiotherapy for head and neck cancer , 1999, Head & neck.

[20]  B. Ma,et al.  Radiotherapy for nasopharyngeal carcinoma--transition from two-dimensional to three-dimensional methods. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[21]  Yaoh-Shiang Lin,et al.  Parotid gland-sparing 3-dimensional conformal radiotherapy results in less severe dry mouth in nasopharyngeal cancer patients: a dosimetric and clinical comparison with conventional radiotherapy. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[22]  S. Leung,et al.  Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience. , 2004, International journal of radiation oncology, biology, physics.

[23]  R. T. Ten Haken,et al.  Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients. , 2005, International journal of radiation oncology, biology, physics.

[24]  C. Ling,et al.  Intensity-modulated radiotherapy versus conventional three-dimensional conformal radiotherapy for boost or salvage treatment of nasopharyngeal carcinoma. , 2002, International journal of radiation oncology, biology, physics.

[25]  S. Kaasa,et al.  Quality of life in patients treated for head and neck cancer: a follow-up study 7 to 11 years after radiotherapy. , 1994, International journal of radiation oncology, biology, physics.

[26]  E. Strong,et al.  Detailed quality of life assessment in patients treated with primary radiotherapy for squamous cell cancer of the base of the tongue , 1997, Head & neck.

[27]  F. Fang,et al.  Computed tomography findings of bony regeneration after radiotherapy for nasopharyngeal carcinoma with skull base destruction: implications for local control. , 1999, International journal of radiation oncology, biology, physics.

[28]  C. Ling,et al.  Intensity-modulated radiotherapy as the boost or salvage treatment of nasopharyngeal carcinoma: the appropriate parameters in the inverse planning and the effect of patient's anatomic factors on the planning results. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[29]  P. Houts,et al.  Quality of life and patients with cancer: a comparative study of patient versus physician perceptions and its implications for cancer education. , 1992, Journal of Cancer Education.

[30]  G. Field,et al.  Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer. , 2002, International journal of radiation oncology, biology, physics.

[31]  Pelayo Vilar,et al.  Nasopharyngeal Carcinoma , 1966 .

[32]  C. Presant.  Quality of life in cancer patients. Who measures what? , 1984, American journal of clinical oncology.

[33]  P. Bhama,et al.  Quality of life in head and neck cancer patients , 2007, Expert review of anticancer therapy.

[34]  L. Dawson,et al.  Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. , 2001, International journal of radiation oncology, biology, physics.

[35]  A. Eisbruch,et al.  A prospective study of hearing loss and inner ear dose in irradiated head and neck cancer patients , 2003 .

[36]  E. Weymuller,et al.  Assessment of quality of life in head and neck cancer patients , 1993, Head & neck.

[37]  James F Dempsey,et al.  Determination and delineation of nodal target volumes for head-and-neck cancer based on patterns of failure in patients receiving definitive and postoperative IMRT. , 2002, International journal of radiation oncology, biology, physics.

[38]  Andrew Bottomley,et al.  EORTC QLQ-C30 Scoring Manual , 1995 .

[39]  Robert L. White,et al.  Phase III quality-of-life study results: impact on patients' quality of life to reducing xerostomia after radiotherapy for head-and-neck cancer--RTOG 97-09. , 2003, International journal of radiation oncology, biology, physics.